NCT06756425

Brief Summary

PURPOSE: The study aims to: Investigate the effect of the designed aerobic exercise program on the blood glucose level (fasting blood glucose and HbA1C) in overweight/ obese pre-diabetic adolescents. 2\) Investigate the effect of the designed aerobic exercise program on the BMI, aerobic capacity, and waist circumference of the participant before and after the designed aerobic exercise program. 3\) Investigate the effect of the designed aerobic exercise program on the quality of life in overweight/ obese pre-diabetic adolescents. 4\) Compare the effect of the diet program only and the diet with a designed aerobic exercise program on the blood glucose level (FBG, HbA1C) and the quality of life of the participants. BACKGROUND: Obesity is defined as a common chronic disorder of excessive body fat. It has become a global epidemic that is present not only in the industrialized world but also in many developing and even underdeveloped countries (Hans, 2017). Overweight children and adolescents often suffer from symptoms of depression and anxiety, poor self-esteem, and social stigma. These psychological aspects complicate global care and affect the quality of life (QOL). The overall QOL score was lower in the overweight and obese groups compared with the normal-weight groups in all the clinical population studies. The published results also indicate that impairment in QOL worsens with a degree of obesity (Marie et al., 2014). HYPOTHESES: There will be no significant difference effect between the diet program only and diet program with a designed aerobic exercise program on blood glucose levels and QOL in overweight/ obese prediabetic adolescents. RESEARCH QUESTION: Does the designed aerobic exercise influence the blood glucose level and the quality of life in pre-diabetic overweight/obese adolescents?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 10, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 4, 2023

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2023

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

December 14, 2024

Completed
20 days until next milestone

First Posted

Study publicly available on registry

January 3, 2025

Completed
Last Updated

January 3, 2025

Status Verified

December 1, 2024

Enrollment Period

5 months

First QC Date

December 14, 2024

Last Update Submit

January 1, 2025

Conditions

Keywords

obesityprediabetesaerobic exercisesquality of lifeblood glucose levelHbA1Cadolescents

Outcome Measures

Primary Outcomes (3)

  • changed HbA1c

    3 months

  • changed BMI

    3 months

  • changed Quality of life questionnaire results

    3 months

Secondary Outcomes (2)

  • changed waist circumference

    3 months

  • changed fasting blood glucose level

    3 months

Study Arms (2)

study group, overweight and obese adolescents with prediabetes

ACTIVE COMPARATOR
Behavioral: aerobic exercise programBehavioral: nutritional health awareness sessions

control group, overweight and obese adolescents with prediabetes

ACTIVE COMPARATOR
Behavioral: nutritional health awareness sessions

Interventions

aerobic exercise program for 3 months with nutritional health awearness sessions

study group, overweight and obese adolescents with prediabetes

lifestyle changes and nutritional awareness sessions for 3 months twice a week for participants and their parents

control group, overweight and obese adolescents with prediabetesstudy group, overweight and obese adolescents with prediabetes

Eligibility Criteria

Age14 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Inclusive criteria: The participants will be selected according to the following criteria: 1. Their ages range from 12 to 18 years old. 2. They will be overweight and obese according to BMI charts of CDC: * Overweight is 85 percentiles to less than the 95 percentile, * Obesity is 95 percentile or greater) (CDC, 2022). 3. They will be prediabetic according to CDC, USPSTF (2022): * HbA1c level of will be 5.7% to 6.4%, * A fasting plasma glucose level will be 100 to 125 mg/dL. 4. Their waist circumference percentiles will be in the area outside of the normal WC curve according to WHO, normal children and adolescents are in the area under the curve (AUC): 0.69 for boys; 0.63 for girls for normal adolescents) (Bo xi et al., 2020) 5. They will be able to follow instructions during evaluation and treatment. Exclusive criteria: Any adolescent with the following criteria will be directly excluded from the evaluation for the consistency of the sample and statistically obtained results: 1. Cardiovascular diseases, 2. Diabetes Mellitus, 3. Morbid obesity more than 120% of the 95 percentile or greater or 35 kg/m or greater. 4. Hearing or visual impairments. 5. Any orthopedic deformities in upper limb or lower limb. 6. Uncontrolled seizures. 7. Receiving any special medications. 8. Participated regularly in sportive activities.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physical Therapy, Cairo University

Giza, Giza Governorate, Egypt

Location

MeSH Terms

Conditions

ObesityPrediabetic State

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

December 14, 2024

First Posted

January 3, 2025

Study Start

September 10, 2022

Primary Completion

February 4, 2023

Study Completion

August 20, 2023

Last Updated

January 3, 2025

Record last verified: 2024-12

Locations